FETAL DISORDERS Flashcards
FETAL DISORDERS etiology
- May be ACQUIRED - Alloimmunization
- May be GENETIC - Congenital Adrenal Hyperplasia, 4alpha Thalassemia
- May be SPORADIC - Structural abnormalities
One of the most frequent causes of
fetal anemia
RED CELL ALLOIMMUNIZATION
Results from transplacental passage of
maternal antibodies that destroy fetal
red cells
RED CELL ALLOIMMUNIZATION
RED CELL ALLOIMMUNIZATION will lead to
overproduction of immature fetal and neonatal red cells ERYTHROBLASTOSIS FETALIS)
RED CELL ALLOIMMUNIZATION detected by
Blood type and Antibody screening during 1 st
PNCU
RED CELL ALLOIMMUNIZATION dx test
- Unbound antibodies detected by INDIRECT COOMB’S TEST
- IgG antibodies are assessed since these are the ones that cross the placenta
- Critical titer for anti D ≥1:16 can cause significant fetal anemia
D negative mother and D positive fetus
increased chance of alloimmunization
- Absence of D Antigen
- Sensitized after single exposure of 0.1 mL of fetal RBCs
D NEGATIVITY
D Sensitization also may occur following
- first trimester pregnancy complications
- prenatal diagnostic procedures
- maternal trauma
Five Red Cell Antigens
c, C, D, E, e
have lower immunogenicity but can cause
hemolytic disease
C, c, E and e Antigens
CDE most common blood group incompatibility
Anti E alloimmunization
greater need for fetal or neonatal transfusion
Anti c alloimmunzation
current pregnancy is jeopardized by maternal antibodies that were initially provoked by his or her grandmother’s erythrocytes
Grandmother effect
Most common cause of hemolytic disease with A and B Blood group antigens
ABO BLOOD GROUP INCOMPATIBILITY
ABO vs CDE Incompatibility
- ABO incompatibility seen in first born
- ABO rarely become more severe in successive pregnancy
- ABO more of pediatric concern
- Most ABO Antibodies don’t cross the placenta (IgM)
- Fetal cells are less immunogenic due to less A and B antigenic sites
ALLOIMMUNIZED PREGNANCY will develop in what
- Mild to moderate hemolytic anemia
- Hydrops fetalis
MANAGEMENT OF ALLOIMMUNIZED PREGNANCY
- Monitoring of titer, repeated every 4 weeks if below the critical level
- If within critical level , further evaluation should be done and no benefit with repeating the titer level
25% to 30% D alloimmunized will develop
mild to moderate hemolytic anemia
25% of alloimmunized pregnancy will develop
hydrops fetalis
MANAGEMENT: DETERMINE FETAL RISK
-40% risk for D Negative mother to have D Negative fetus
-Amnestic Response - Patient is sensitized from previous exposure but titer may be elevated with
current pregnancy even if the fetus is D Negative
-Initial evaluation
*Determine paternal erythrocyte antigen status
*Paternal zygosity
*Fetal genotype